Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2007
10/04/2007US20070232559 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
10/04/2007US20070232551 Treatment for Cardiovascular Disease
10/04/2007US20070232535 GFRalpha3 and its uses
10/04/2007US20070231849 Hyperpolarizing with potential-sensitive fluorescent dye and isoosmolar sodium-ion-free buffer, incubating, determining membrane potential, adding sodium, recording change in potential; voltage sensitive oxonol dyes; sodium channel modulators; high throughput screening; fluorescent imaging plate reader
10/04/2007US20070231405 Compositions and Methods Using Same for Treating Neurodegenerative Disorders
10/04/2007US20070231395 Solid Pharmaceutical Preparation for Dialysis
10/04/2007US20070231376 Methods and compositions for modulating axonal outgrowth of central nervous system neurons
10/04/2007US20070231372 Tissue Sealant
10/04/2007US20070231327 Anti-CCR5 antibodies
10/04/2007US20070231326 Immunological Methods of Treating Cancer
10/04/2007US20070231297 Methods related to wound healing
10/04/2007US20070231272 Process for Preparing Inhalable Powders
10/04/2007US20070231269 Analgesics
10/04/2007US20070231266 Diagnosis of macrophage mediated disease
10/04/2007CA2647048A1 Methods for treating cognitive and other disorders
10/04/2007CA2645496A1 Gdf-9/bmp-15 modulators for the treatment of bone disorders
10/04/2007CA2642880A1 Stable oral pharmaceutical composition containing thyroid hormone receptor agonists
10/04/2007CA2583978A1 Surface-modified materials, such as contact lenses, methods and kits for their preparation, and uses thereof
10/03/2007EP1840215A1 Method of inhibiting telomerase activity and inhibitor
10/03/2007EP1839675A1 Novel method of protecting ischemic cardiopathy
10/03/2007EP1839674A1 CD40 antagonist for treating psoriasis
10/03/2007EP1839662A1 Antitumor agent
10/03/2007EP1839657A2 A method for treating vascular headaches
10/03/2007EP1839648A2 An inhalation system
10/03/2007EP1838392A2 Selenium-containing medicaments for the prevention or treatment of endothelial vascular diseases
10/03/2007EP1838350A2 Modulators of itch ubiquitinase activity
10/03/2007EP1838328A2 Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts
10/03/2007EP1838319A2 Pde5 inhibitor compositions and methods for immunotherapy
10/03/2007EP1838313A2 Pharmaceutical composition comprising nifedipine and mesalazine for the treatment of rectoanal tenesmus
10/03/2007EP1838294A1 Compositions comprising pde4 modulators and their use for the treatment or prevention of airway inflammation
10/03/2007EP1699451B1 Use of silibinin together with alpha-liponic acid for the treatment of chronic obstructive pulmonary diseases
10/03/2007EP1589976B1 Use of a combination of an aromatase inhibitor, a progestin and an oestrogen for the treatment of endometriosis
10/03/2007EP1575598B1 Pharmaceutical compositions comprising a combination of calcitriol and clobetasol propionate
10/03/2007EP1463493B1 Methods of inducing ovulation-using a non-polypeptide camp level modulator
10/03/2007EP1461093B1 Milk protein biofilm and uses thereof
10/03/2007EP1368054B1 Using neural thread proteins to treat tumors
10/03/2007EP1366161B1 Antagonist anti-pro842 antibody
10/03/2007EP1362855B1 Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
10/03/2007EP1355631B1 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
10/03/2007EP1351968B1 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
10/03/2007EP1351744B1 Use of specific erbb4 antagonists for treating stenosis
10/03/2007EP1337285B1 Implants with a phosphazene-containing coating
10/03/2007EP1309339B1 Stimulating neutrophil function to treat inflammatory bowel disease
10/03/2007EP1306093B1 Nerve regeneration promoters containing semaphorin inhibitor as the active ingredient
10/03/2007EP1294378B1 Thrombopoietin mimetics
10/03/2007EP1267839B1 Microspheres for active embolization
10/03/2007EP1262490B1 GPib-LIPID BOND CONSTRUCT AND USE THEREOF
10/03/2007EP1135482B1 Cancer cell vaccine
10/03/2007EP1023081B1 Use of recombinant human uteroglobin in treatment of fibrotic conditions
10/03/2007CN101048180A Solid formulation with improved solubility and stability, and method for producing said formulation
10/03/2007CN101045164A Double-chain structured polyethylene active derivatives, and ligature with other molecules
10/03/2007CN101045163A High molecular anticarcinogenic prodrug, its preparing method and use
10/03/2007CN101045161A Modulators of P-selectin glycoprotein ligand 1
10/03/2007CN101045155A Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
10/03/2007CN101045052A Medicine composition for treating cardiovascular disease
10/03/2007CN101045035A Anticancer composite carried with tyrosine kinase inhibitor and phosphoinositide 3-kinase inhibitor
10/03/2007CN101045034A Bioadhesive drug delivery system
10/03/2007CN100340661C Bone marrow interstital stem cell preparation and its combined use with controlled release neurotrophic factor
10/03/2007CN100340575C Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
10/03/2007CN100340297C Anticarcinogenic internal implant agent
10/03/2007CN100340296C Anticarcinogenic internal implant agent
10/03/2007CN100340295C Oral administered compound colloid pectin bismuth preparation and its preparing process
10/03/2007CN100340294C Remedy for spinal injury containing interleukin-6 antagonist
10/03/2007CN100340293C Hair growth stimulants, percutaneous preparations and method of stimulating hair growth
10/03/2007CN100340291C F1t4(VEGFR-3) as target for tumor imaging and anti-tumor therapy
10/03/2007CN100340287C Methods of preventing UVB-induced skin damage
10/03/2007CN100340237C Transdermal drug delivery system with improved water absorbability and adhesion properties
10/02/2007US7277534 Communications system and method
10/02/2007US7276612 For hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides
10/02/2007US7276539 In which the phenyl group is p-substituted with a 2-(p-(methylsulfonyloxy)phenoxy)ethyl group; used for treating type 2 diabetes and dyslipidemia; may be combined with atorvastatin, rosuvastatin, or an IBAT inhibitor.
10/02/2007US7276533 Compositions useful for the treatment of pathologies responding to the activation of PPAR-gamma receptor
10/02/2007US7276525 Administering either simultaneously or sequentially a bone morphogenic protein and a compound having a transforming growth factor-beta selective inhibitory activity, particularly 4-(4-benzo[1,3]dioxol-5-yl-5-pyridin-2-yl-1H-imidazol-2-yl)benzamide
10/02/2007US7276514 Prevent tissue damage prevent stroke, headaches
10/02/2007US7276513 Steroidal compounds for inhibiting steroid sulphatase
10/02/2007US7276510 Viricides; prevent reproduction of human T-Cell lymphocyte virus
10/02/2007US7276503 Administration of optically pure (S,S) reboxetine, or a salt thereof; diminished adverse side effects
10/02/2007US7276478 Methods of treating autoimmune diseases using IL-21
10/02/2007US7276468 Neutralizes the adverse health effects of both chemical and biological compounds, especially chemical warfare (CW) and biological warfare (BW) agents
10/02/2007US7276372 Antibodies against GPR64 and uses thereof
10/02/2007US7276364 Nucleic acids encoding endotheliases, endotheliases and uses thereof
10/02/2007US7276252 Material handling of toxic drugs; multilayer forms
10/02/2007US7276249 Phospholipid-free, having a D50 particle size of less than 500 nm, andhaving a surface stabilizer; improved pharmacokinetic profiles and reduced fed/fasted variability
10/02/2007US7276245 Administering a botulinum toxin
10/02/2007US7276228 Methods for treating hematological disorders through inhibition of DNA methylation and histone deacetylase
10/02/2007CA2449244C Negatively charged amphiphilic block copolymer as drug carrier and complex thereof with positively charged drug
10/02/2007CA2413424C Substituted bicyclic derivatives for the treatment of abnormal cell growth
10/02/2007CA2378613C Selective iglur5 receptor antagonists for the treatment of migraine
10/02/2007CA2296653C Treatment of diabetes with thiazolidinedione, insulin secretagogue and biguanide
10/02/2007CA2251114C Treatment of arthritis disorders, rheumatoid arthritis and manifestations associated with rheumatoid disorders
09/2007
09/27/2007WO2007109142A2 M3 muscarinic receptor antagonists for treating tumors
09/27/2007WO2007108557A1 Control of intracellular target molecule by ip3 receptor-binding protein
09/27/2007WO2007107843A1 Methods of treatment with cetp inhibitors
09/27/2007WO2007107318A1 Pharmaceutical combination composition comprising at least one pkc inhibitor and at least one jak3 kinase inhibitor for treating autoimmune disorders
09/27/2007WO2007092458A8 Antidotes to exogenous neurotoxic agents
09/27/2007WO2007041279A3 Methods to treat t-cell disorders using tisf
09/27/2007WO2007000764A3 Compositions and methods for enhancement of sexual function
09/27/2007WO2006124862A3 Methods for the treatment of ocular and neurodegenerative conditions in a mammal
09/27/2007US20070225727 Transparent Tissue-Visualizng Preparation
09/27/2007US20070225361 Dimeric compounds and their use as anti-viral agents
09/27/2007US20070225359 Dimeric compounds and their use as anti-viral agents
1 ... 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 ... 1151